Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort ascending
Feb
3
2022
COVID-19 Vaccine Update – February 2022 Robinson & Cole LLP
Sep
27
2022
DOJ Announces $900 Million Settlement Tied to Speaker Bureau Payments to Physicians Robinson & Cole LLP
Sep
24
2019
DOJ Reaches $21.36 Million Agreement with Compounding Pharmacy, Two of its Executives, and Managing Private Equity Firm to Resolve FCA Allegations Robinson & Cole LLP
Jun
15
2022
Supreme Court Decides in Favor of 340B Hospitals Regarding Medicare Reimbursement Methodology Robinson & Cole LLP
Jul
12
2019
Connecticut Legislature Modifies Statutes Relevant to Preventing and Treating Opioid Use Disorder Robinson & Cole LLP
Jun
9
2023
Connecticut Governor’s Health Care Bill Makes Important Changes to the Certificate of Need Process Robinson & Cole LLP
Mar
18
2020
DEA Allows Providers to Prescribe Controlled Substances Without an In-Person Medical Examination During COVID-19 Public Health Emergency Robinson & Cole LLP
Jan
14
2021
Privacy Tip #267 – Fertility Tracking App Settles with FTC Robinson & Cole LLP
Feb
15
2022
The Joint Commission Announces COVID-19 Vaccine Surveys Have Begun Robinson & Cole LLP
Mar
25
2020
COVID-19 Vaccine Test Lab Hit by Maze Ransomware Robinson & Cole LLP
Apr
9
2020
Massachusetts Issues COVID-19 Orders and Guidance for Providers Robinson & Cole LLP
Apr
30
2020
ExecuPharm Data Stolen in Ransomware Attack Published on Internet Robinson & Cole LLP
Jan
3
2019
Data Privacy and Security in the Cannabis Industry Robinson & Cole LLP
May
15
2019
CMS Final Rule on Drug Pricing Transparency in Consumer Television Ads Robinson & Cole LLP
Jul
3
2019
Privacy Tip #197 — Medtronic 508 (MiniMed) Insulin Pumps Recalled Robinson & Cole LLP
Jan
29
2020
DOJ Announces Settlement with EHR Company to Resolve Criminal and Civil Kickback Investigations Tied to Opioid Prescribing Robinson & Cole LLP
Feb
6
2020
30,000 Cannabis Users’ Data Exposed Robinson & Cole LLP
Mar
17
2020
Massachusetts Issues COVID-19 Guidance for Health Care Providers, Payors and Laboratories on Issues Including Telehealth, Elective Procedures, COVID-19 Testing, and Expedited Provider Licensure Robinson & Cole LLP
Nov
4
2023
Privacy Tip #378 – Bad Actors Selling Data of 23andMe Users of Ashkenazi Jewish and Chinese Descent Robinson & Cole LLP
Aug
5
2021
Maine Requires Companies to Pay For Their Packaging Robinson & Cole LLP
Nov
16
2021
HHS Again Requires FDA Premarket Review for COVID-19 Tests Robinson & Cole LLP
Feb
15
2022
The Joint Commission Announces COVID Vaccine Surveys Have Begun Robinson & Cole LLP
May
12
2023
DEA Extends Pandemic Telehealth Prescribing Flexibilities For Up To 18 Months Robinson & Cole LLP
Jun
13
2023
Connecticut Health Care Bill Revises Provider-Payor Contracting Requirements to Address Competitive Concerns Robinson & Cole LLP
Jul
16
2020
Reinventing Supply Chains to Reach Patients in Remote Areas Robinson & Cole LLP
Feb
8
2019
Genetic Testing Comes at a Cost Robinson & Cole LLP
Jul
9
2019
Federal Judge Vacates Final Rule on Drug Pricing Transparency in Consumer Advertising Robinson & Cole LLP
Aug
15
2019
Allscripts Announces $145 Million Preliminary Settlement with DOJ Related to an Investigation of Practice Fusion, a Recently Acquired EHR Company Robinson & Cole LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins